Company / Revenue per Share
West Pharmaceutical Services Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$42.52
FY2025
5-year range
$24.86 / $42.52
FY2021-FY2025
Trend
+8.0%
vs FY2024
Sector context
#44 of 153
Health Care
What the data says
At $42.52, West Pharmaceutical Services's revenue per share ranks #44 of 153 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $19.66 in FY2016 to $42.52 in FY2025.
Based on SEC 10-K filings.
42.52 in FY2025 with a 5-year CAGR of +12.9%.
Improved from $39.81 to $42.52 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +13.7%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Sector benchmark
#44 of 153 in Health CareTop 29% of 153This company $42.52 Sector average $123.89
▼
-65.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 8.0% year-over-year.
- Ranks #44 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.52 | +8.0% |
| FY2024 | $39.36 | -1.1% |
| FY2023 | $39.81 | +37.6% |
| FY2022 | $28.93 | +16.4% |
| FY2021 | $24.86 | +7.3% |
| FY2020 | $23.18 | -6.7% |
| FY2019 | $24.83 | +6.8% |
| FY2018 | $23.24 | +6.2% |
| FY2017 | $21.88 | +11.3% |
| FY2016 | $19.66 | +2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026